Cited by 282Radiomics and Machine Learning in Medical ImagingMRI in cancer diagnosisBreast Cancer Treatment Studies

Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment

Pinker, Katja, Chin, Joanne, Melsaether, Amy N., Morris, Elizabeth A., Moy, Linda·2018·Radiology

Abstract

Precision medicine is medicine optimized to the genotypic and phenotypic characteristics of an individual and, when present, his or her disease. It has a host of targets, including genes and their transcripts, proteins, and metabolites. Studying precision medicine involves a systems biology approach that integrates mathematical modeling and biology genomics, transcriptomics, proteomics, and metabolomics. Moreover, precision medicine must consider not only the relatively static genetic codes of individuals, but also the dynamic and heterogeneous genetic codes of cancers. Thus, precision medicine relies not only on discovering identifiable targets for treatment and surveillance modification, but also on reliable, noninvasive methods of identifying changes in these targets over time. Imaging via radiomics and radiogenomics is poised for a central role. Radiomics, which extracts large volumes of quantitative data from digital images and amalgamates these together with clinical and patient data into searchable shared databases, potentiates radiogenomics, which is the combination of genetic and radiomic data. Radiogenomics may provide voxel-by-voxel genetic information for a complete, heterogeneous tumor or, in the setting of metastatic disease, set of tumors and thereby guide tailored therapy. Radiogenomics may also quantify lesion characteristics, to better differentiate between benign and malignant entities, and patient characteristics, to better stratify patients according to risk for disease, thereby allowing for more precise imaging and screening. This report provides an overview of precision medicine and discusses radiogenomics specifically in breast cancer. © RSNA, 2018

Integrity signals

Registry

Crossref · 10.1148/radiol.2018172171

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In oncology applications, radiological images and genomic information of cancer patients have been integrated for enhanced prognosis prediction and patient classification.

    “In oncology applications, the radiological images and genomic information of cancer patients have been integrated for enhanced prognosis prediction and patient classification [17].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pinker, K., Chin, J., Melsaether, A. N., Morris, E. A., & Moy, L.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Venue
Radiology
Published
2018-06
Volume
287
Issue
3
Pages
732-747
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W2803669118
Cited by
275
References
140
Citations by year
2026: 18 · 2025: 27 · 2024: 31 · 2023: 44 · 2022: 43 · 2021: 42 · 2020: 35 · 2019: 24 · 2018: 11
FWCI
4.46
Type
journal article
Language
en
Open access
closed
Locations
  • Radiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
precision medicine, radiogenomics, radiomics, breast cancer, tumor heterogeneity, metastatic breast cancer, benign versus malignant differentiation, risk stratification, cancer screening, multimodal data integration, systems biology
MeSH terms
Breast Neoplasms, Female, Humans, Image Interpretation, Computer-Assisted, Mammography, Radiology, Biomarkers, Tumor, Genetic Predisposition to Disease, Genomics, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review